Regulation of Hepatitis C Virus Replication by Interferon Regulatory Factor 1

  • Nobuhiko Kanazawa
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Masayuki Kurosaki
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Naoya Sakamoto
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Nobuyuki Enomoto
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Yasuhiro Itsui
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Tsuyoshi Yamashiro
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Yoko Tanabe
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Shinya Maekawa
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Mina Nakagawa
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Cheng-Hsin Chen
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Sei Kakinuma
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Shigeru Oshima
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Tetsuya Nakamura
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University
  • Takanobu Kato
    Department of Microbiology, Tokyo Metropolitan Institute for Neuroscience, Tokyo
  • Takaji Wakita
    Department of Microbiology, Tokyo Metropolitan Institute for Neuroscience, Tokyo
  • Mamoru Watanabe
    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University

抄録

<jats:title>ABSTRACT</jats:title> <jats:p>Cellular antiviral responses are mediated partly by the expression of interferon-stimulated genes, triggered by viral genomes, their transcripts and replicative intermediates. Persistent replication of a hepatitis C virus (HCV) replicon suggests that the replicon does not elicit cellular innate antiviral responses. In the present study, we investigated regulatory factors of the interferon-mediated antiviral system in cells expressing an HCV replicon. Luciferase reporter assays revealed that the baseline activity of the interferon-stimulated response element (ISRE) was significantly lower in cells harboring the replicon than in naive cells. Among the proteins involved in the IFN/Jak/STAT pathway and in ISRE activity, the expression level of interferon regulatory factor 1 (IRF-1) was found to be significantly lower in cells harboring the replicon. Transfection of an IRF-1 expression construct into cells harboring the replicon caused an increase of ISRE activity, accompanied by suppression of expression of the HCV replicon. Moreover, in cured Huh7 cells from which the HCV replicon had been eliminated, the expression levels of IRF-1 and ISRE activity also were suppressed, demonstrating that the decrease of IRF-1 is attributable, not to active suppression by the viral proteins, but to adaptation of cells that enables replication of the HCV subgenome. The high permissiveness of the cured cells for the replicon was abolished by transgenic supplementation of IRF-1 expression. Taken together, IRF-1 is one of the key host factors that regulate intracellular HCV replication through modulation of interferon-stimulated-gene-mediated antiviral responses.</jats:p>

収録刊行物

  • Journal of Virology

    Journal of Virology 78 (18), 9713-9720, 2004-09-15

    American Society for Microbiology

被引用文献 (7)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ